PL2916823T3 - Produkt współmikronizacji zawierający selektywny modulator receptora progesteronu - Google Patents

Produkt współmikronizacji zawierający selektywny modulator receptora progesteronu

Info

Publication number
PL2916823T3
PL2916823T3 PL13801640T PL13801640T PL2916823T3 PL 2916823 T3 PL2916823 T3 PL 2916823T3 PL 13801640 T PL13801640 T PL 13801640T PL 13801640 T PL13801640 T PL 13801640T PL 2916823 T3 PL2916823 T3 PL 2916823T3
Authority
PL
Poland
Prior art keywords
progesterone receptor
receptor selective
selective modulator
micronisation
product
Prior art date
Application number
PL13801640T
Other languages
English (en)
Inventor
Florian Battung
Pierre-Yves Juvin
Jérôme Hecq
Aude Colin
Original Assignee
Laboratoire Hra Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Hra Pharma filed Critical Laboratoire Hra Pharma
Publication of PL2916823T3 publication Critical patent/PL2916823T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
PL13801640T 2012-11-08 2013-11-07 Produkt współmikronizacji zawierający selektywny modulator receptora progesteronu PL2916823T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260605A FR2997628B1 (fr) 2012-11-08 2012-11-08 Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
EP13801640.7A EP2916823B1 (fr) 2012-11-08 2013-11-07 Produit de co-micronisation comprenant un modulateur selectif du recepteur a la progesterone

Publications (1)

Publication Number Publication Date
PL2916823T3 true PL2916823T3 (pl) 2017-08-31

Family

ID=47714259

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13801640T PL2916823T3 (pl) 2012-11-08 2013-11-07 Produkt współmikronizacji zawierający selektywny modulator receptora progesteronu

Country Status (22)

Country Link
US (1) US20150258118A1 (pl)
EP (1) EP2916823B1 (pl)
JP (1) JP2015536969A (pl)
CN (1) CN105073098B (pl)
CR (1) CR20150298A (pl)
CY (1) CY1118884T1 (pl)
DK (1) DK2916823T3 (pl)
EA (1) EA029643B1 (pl)
EC (1) ECSP15022505A (pl)
ES (1) ES2625012T3 (pl)
FR (1) FR2997628B1 (pl)
GE (1) GEP201706648B (pl)
HR (1) HRP20170686T1 (pl)
LT (1) LT2916823T (pl)
MD (1) MD4546C1 (pl)
PL (1) PL2916823T3 (pl)
PT (1) PT2916823T (pl)
RS (1) RS55956B1 (pl)
SI (1) SI2916823T1 (pl)
SM (1) SMT201700237T1 (pl)
UA (1) UA115573C2 (pl)
WO (1) WO2014072647A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265533A (zh) * 2016-10-10 2017-01-04 朱隆娅 一种阿德呋啉颗粒剂及其制备方法
FR3060389B1 (fr) * 2016-12-20 2019-05-31 Laboratoire Hra-Pharma Comprime enrobe comprenant de l'ulipristal acetate ou un de ses metabolites
EP3895691A1 (en) 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Ulipristal acetate otf
US11878025B2 (en) 2021-09-06 2024-01-23 Slayback Pharma Llc Pharmaceutical compositions of mifepristone

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
JP2004099442A (ja) * 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
ES2212912B1 (es) 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
JP5017109B2 (ja) 2004-07-09 2012-09-05 ザ・ポピュレイション・カウンシル，インコーポレイテッド プロゲステロン受容体モジュレーターを含有する徐放性組成物
MY150763A (en) * 2006-10-24 2014-02-28 Repros Therapeutics Inc Compositions and methods for suppressing endometrial proliferation
JP2010514793A (ja) * 2006-12-28 2010-05-06 レプロス セラピューティクス インコーポレイティド 抗プロゲスチンのバイオアベイラビリティを改善するための方法および製剤
JP2008169135A (ja) * 2007-01-11 2008-07-24 Takada Seiyaku Kk グリメピリド組成物の製造方法
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
WO2010119029A1 (en) 2009-04-14 2010-10-21 Laboratoire Hra-Pharma Method for on-demand contraception
EP2535114A4 (en) * 2009-11-13 2015-11-18 Moriroku Chemicals Company Ltd FINE POWDER MANUFACTURING METHOD AND FINE POWDER PRODUCED BY THIS METHOD
FR2988610B1 (fr) * 2012-03-30 2014-10-31 Effik Progestatif co-micronise avec un polymere portant le groupe pyrrolidone, composition et utilisations
CN102871977A (zh) * 2012-10-19 2013-01-16 北京紫竹药业有限公司 醋酸优力司特分散片及其制备方法

Also Published As

Publication number Publication date
MD4546C1 (ro) 2019-03-31
HRP20170686T1 (hr) 2017-09-08
WO2014072647A1 (fr) 2014-05-15
UA115573C2 (uk) 2017-11-27
EA201500514A1 (ru) 2015-09-30
RS55956B1 (sr) 2017-09-29
EA029643B1 (ru) 2018-04-30
MD20150054A2 (ro) 2015-10-31
US20150258118A1 (en) 2015-09-17
EP2916823A1 (fr) 2015-09-16
DK2916823T3 (en) 2017-05-15
ECSP15022505A (es) 2016-01-29
CN105073098B (zh) 2019-02-19
MD4546B9 (ro) 2018-08-31
GEP201706648B (en) 2017-03-27
CN105073098A (zh) 2015-11-18
SMT201700237T1 (it) 2017-07-18
JP2015536969A (ja) 2015-12-24
FR2997628B1 (fr) 2015-01-16
MD4546B1 (ro) 2018-01-31
PT2916823T (pt) 2017-05-22
FR2997628A1 (fr) 2014-05-09
ES2625012T3 (es) 2017-07-18
CR20150298A (es) 2015-08-14
CY1118884T1 (el) 2018-01-10
SI2916823T1 (sl) 2017-08-31
EP2916823B1 (fr) 2017-02-15
LT2916823T (lt) 2017-07-25

Similar Documents

Publication Publication Date Title
AP3338A (en) Glucagon receptor modulator
EP2838803A4 (en) PACKAGING SYSTEM
IL234129B (en) Dispensing system
IL234221B (en) Dispensing system
AP2014007548A0 (en) Selective androgen receptor modulators
EP2897466A4 (en) Coupler for decorating bag
PL2936468T3 (pl) Urządzenie do wykrywania pożaru
ZA201500096B (en) Indolecarbonitriles as selective androgen receptor modulators
IL239076B (en) Modulators and selective androgen receptor
GB2498796B (en) Pill dispensing device
IL238347A0 (en) division system
SMT201700237T1 (it) Prodotto di co-micronizzazione che comprende un modulatore selettivo del recettore del progesterone
PL2890504T3 (pl) Urządzenie do dozowania cząstek stałych
GB201223053D0 (en) Receptor
GB201220124D0 (en) A microfluid device
PL2917128T3 (pl) Urządzenie do dozowania kremów
GB201218814D0 (en) A dosing device
GB201222485D0 (en) Product provisioning system
GB201203283D0 (en) Product provisioning system
GB201212127D0 (en) A stirring device
AU345610S (en) A carrying device
GB201207330D0 (en) Tablet dispensing device
GB201209642D0 (en) Dispensing system